Although a majority of respondents had insurance, nearly half of respondents spent more than $500 last year on migraine related treatment and therapies. Another 19% spent between $251-$500 to cover migraine related care.
Among preventive migraine medications, antiepileptic drugs were currently used by almost a third of users and antidepressants by over 1⁄4. However over half of current antidepressant users suffered from depression and/or anxiety, so usage may also be to treat these conditions and not migraine exclusively. Despite having the highest abandonment rate, Antiepileptic drugs had the highest level of satisfaction among current preventive users (51%).